Antiaging gene Klotho regulates endothelin-1 levels and endothelin receptor subtype B expression in kidneys of spontaneously hypertensive rats

Journal of Hypertension

Volumn 32, Issue 8, 2014, Pages 1629-1636

  Wang, Yuhong ^a   Sun, Zhongjie ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

adeno associated virus; endothelin 1; klotho; spontaneously hypertensive rat; superoxide dismutase

Indexed keywords

ADENOVIRUS VECTOR; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; KLOTHO PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; PHOSPHATE BUFFERED SALINE; BETA GLUCURONIDASE; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; KLOTHO GENE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; WISTAR KYOTO RAT; ANIMAL; BLOOD; CHEMISTRY; GENETICS; HYPERTENSION; KIDNEY; METABOLISM; PHYSIOLOGY;

ANIMALS; ENDOTHELIN-1; GLUCURONIDASE; HYPERTENSION; KIDNEY; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SUPEROXIDE DISMUTASE;

EID: 84904057558     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000233     Document Type: Article

References (42)

1. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390:45-51. (Pubitemid 27494749)
2. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone klotho. Science 2005; 309:1829-1833. (Pubitemid 41325087)
3. Wang Y, Sun Z. Current understanding of klotho. Ageing Res Rev 2009; 8:43-51.
4. Hu MC, Kuro-o M, Moe OW. Klotho and kidney disease. J Nephrol 2010; 23 (Suppl 16):S136-S144.
5. Wang Y, Sun Z. Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 2009; 54:810-817.
6. Bernheim J, Benchetrit S. The potential roles of FGF23 and klotho in the prognosis of renal and cardiovascular diseases. Nephrol Dial Transplant 2011; 26:2433-2438.
7. Milovanova L, Kozlovskaia LV, Milovanov Iu S, Bobkova IN, Dobrosmyslov IA. Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and klotho. Ter Arkh 2010; 82:66-72.
8. Kohan DE, Padilla E. Endothelin-1 production by rat inner medullary collecting duct: effect of nitric oxide, cGMP, and immune cytokines. Am J Physiol 1994; 266:F291-F297.
9. Levin ER. Endothelins. N Engl J Med 1995; 333:356-363.
10. Abassi ZA, Ellahham S, Winaver J, Hoffman A. The intrarenal endothelin system and hypertension. News Physiol Sci 2001; 16:152-156. (Pubitemid 33713261)
11. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46:325-415.
12. Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag 2008; 4:1061-1068.
13. Abman SH. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. Annu Rev Med 2009; 60:13-23.
14. MacLean MR, McCulloch KM, Baird M. Endothelin ETA-and ETBreceptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol 1994; 23:838-845.
15. Davie N, Haleen SJ, Upton PD, Polak JM, Yacoub MH, Morrell NW, et al. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2002; 165:398-405. (Pubitemid 34118516)
16. Frommer KW, Muller-Ladner U. Expression and function of ETA and ETB receptors in SSc. Rheumatology (Oxford) 2008; 47 (Suppl 5):v27-v28.
17. Ivey ME, Osman N, Little PJ. Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis. Atherosclerosis 2008; 199:237-247.
18. Stauffer BL, Westby CM, DeSouza CA. Endothelin-1, aging and hypertension. Curr Opin Cardiol 2008; 23:350-355. (Pubitemid 351787100)
19. Wang X, Skelley L, Cade R, Sun Z. AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther 2006; 13:1097-1103.
20. Crosswhite P, Sun Z. Inhibition of phosphodiesterase 1 attenuates cold-induced pulmonary hypertension. Hypertension 2013; 61:585-592.
21. Sun Z, Bello-Roufai M, Wang X. RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension. Am J Physiol 2008; 294:H1880-H1887. (Pubitemid 351490617)
22. Wang X, Cade R, Sun Z. Human eNOS gene delivery attenuates coldinduced elevation of blood pressure in rats. Am J Physiol 2005; 289: H1161-H1168. (Pubitemid 41213346)
23. Nakano D, Pollock D. New concepts in endothelin control of sodium balance. Clin Exp Pharmacol Physiol 2012; 39:104-110.
24. Duerrschmidt N, Wippich N, Goettsch W, Broemme HJ, Morawietz H. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem Biophys Res Commun 2000; 269:713-717. (Pubitemid 30440367)
25. Khraibi AA, Heublein DM, Knox FG, Burnett JC Jr. Increased plasma level of endothelin-1 in the Okamoto spontaneously hypertensive rat. Mayo Clin Proc 1993; 68:42-46. (Pubitemid 23018156)
26. Naruse M, Tanabe A, Naruse K, Adachi C, Yoshimoto T, Seki T, et al. Hemodynamic and biochemical effects of endothelin-A-and-B-receptor antagonist TAK-044 in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2000; 36 (5 Suppl 1): S334-S336.
27. Nyberg M, Mortensen SP, Hellsten Y. Physical activity opposes the agerelated increase in skeletal muscle and plasma endothelin-1 levels and normalizes plasma endothelin-1 levels in individuals with essential hypertension. Acta Physiol (Oxf) 2013; 207:524-535.
28. Kohan DE. Endothelin, hypertension and chronic kidney disease: new insights. Curr Opin Nephrol Hypertens 2010; 19:134-139.
29. Dhaun N, Goddard J, Kohan DE, Pollock DM, Schiffrin EL, Webb DJ. Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension 2008; 52:452-459.
30. Prasad VS, Palaniswamy C, Frishman WH. Endothelin as a clinical target in the treatment of systemic hypertension. Cardiol Rev 2009; 17:181-191.
31. Xiao NM, Zhang YM, Zheng Q, Gu J. Klotho is a serum factor related to human aging. Chin Med J 2004; 117:742-747. (Pubitemid 38735835)
32. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49:69-75. (Pubitemid 46360343)
33. Zeng C, Hopfer U, Asico LD, Eisner GM, Felder RA, Jose PA. Altered AT1 receptor regulation of ETB receptors in renal proximal tubule cells of spontaneously hypertensive rats. Hypertension 2005; 46:926-931.
34. Ge Y, Bagnall A, Stricklett PK, Webb D, Kotelevtsev Y, Kohan DE. Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention. Am J Physiol Renal Physiol 2008; 295:F1635-F1640.
35. Sauvageau S, Thorin E, Caron A, Dupuis J. Endothelin-1-induced pulmonary vasoreactivity is regulated by ET(A) and ET(B) receptor interactions. J Vasc Res 2007; 44:375-381. (Pubitemid 47312658)
36. Camici GG, Sudano I, Noll G, Tanner FC, Luscher TF. Molecular pathways of aging and hypertension. Curr Opin Nephrol Hypertens 2009; 18:134-137.
37. Pollock DM, Pollock JS. Endothelin and oxidative stress in the vascular system. Curr Vasc Pharmacol 2005; 3:365-367. (Pubitemid 41264289)
38. Pfab T, Thone-Reineke C, Theilig F, Lange I, Witt H, Maser-Gluth C, et al. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure. J Am Soc Nephrol 2006; 17:1082-1089.
39. Stricklett PK, Hughes AK, Kohan DE. Endothelin-1 stimulates NO production and inhibits cAMP accumulation in rat inner medullary collecting duct through independent pathways. Am J Physiol Renal Physiol 2006; 290:F1315-F1319. (Pubitemid 43830755)
40. Skalska AB, Pietrzycka A, Stepniewski M. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin Biochem 2009; 42:358-364.
41. Bohm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007; 76: 8-18. (Pubitemid 47362047)
42. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 1994; 266:H2568-H2572. (Pubitemid 24215893)